Neurosyphilis is the infection of spinal cord and brain. It is most common in an individual
who have untreated syphilis for long period of time. This is mainly caused due to bacteria
called Treponema pallidum. This is the bacteria which causes syphilis. After getting infected
with syphilis for the first time, there are chances of neurosyphilis after 10-20 years later.
The major symptoms of neurosyphilis are blindness, abnormal walk, confusion, depression,
dementia, headache, irritability, incontinence, poor concentration, numbness in the toes,
feet, or legs, seizures, tremors, stiff neck, visual disturbances, and weakness. There are
possibility of no symptoms of neurosyphilis. Out of all types of neurosyphilis, asymptomatic
neurosyphilis is the most common type.
The Global Neurosyphilis Market is growing steadily and is expected to continue its growth
during the forecast period. Global Neurosyphilis Market is expected to grow at the CAGR of
~3.9% during the forecast period and is estimated to reach USD 957.4 million by 2023.
Considering the market scenario of global neurosyphilis, increasing funding for research,
clinical trials, and new product development are driving the growth for the market.
Government and companies are investing large amount of money to derive effective cure
for neurosyphilis. Adoption of technologically advanced diagnostic medical devices are
another important driver for the market. Some other factors like increasing awareness,
rising demand from emerging markets, government support to improve public healthcare,
and changing healthcare practices are also major factors for the market growth.
Segments:
Global Neurosyphilis Market has been segmented on the basis of type which comprise
asymptomatic neurosyphilis, meningeal neurosyphilis, meningovascular neurosyphilis,
general paresis, tabes dorsalis, and others.
On the basis of diagnosis, the market is segmented into physical exam, blood test, spinal
tap, imaging tests, and others. Blood test is further subsegmented into Venereal disease
research laboratory (VDRL) test, Fluorescent treponemal antibody absorption (FTA-ABS),
Rapid plasma reagin (RPR), Treponema pallidum particle agglutination assay (TPPA), and
others. Imaging tests is further sub-segmented into Computed Tomography (CT), X-rays,
Magnetic resonance imaging (MRI), and others.
On the basis of treatments, the market has been segmented into antibiotic penicillin,
antibiotics probenecid, ceftriaxone and others. Antibiotic penicillin is further sub-segmented
into Injection and oral.
On the basis of end user, it is segmented into hospital and clinics, medical research centers,
academic institutes, and others.
Key players for global neurosyphilis market:
Abbott (US), Bayer AG (Germany), Eli Lilly and Company (US), GlaxoSmithKline plc. (UK),
Novartis AG (Switzerland), Pfizer Inc. (US), Sanofi (France), and others.
Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/4021 .
Regional analysis of global neurosyphilis market:
Considering the global scenario of the market, the Americas are holding the largest market
for neurosyphilis. The Americas mainly include North America and Latin America, out of
which North America is holding majority of market share of this region. US is the top
revenue generating market in North America and is one of the important markets for global
neurosyphilis. Various factors are leading the market growth such as availability of funding
for research and clinical trials, and advanced diagnostic and treatment options. Latin
America neurosyphilis market is also growing significantly and mainly includes Brazil,
Argentina and Chile. Europe is the second largest and one of the important markets for
neurosyphilis. Increasing cases of neurosyphilis is a key driving factor for this market.
Europe is mainly divided into Eastern Europe and Western Europe. More developed western
European countries like Germany, UK and France are dominating this market while East
European region is also growing significantly. Asia Pacific region is showing the fastest
growth rate in global neurosyphilis market due to some major factors such as increasing
awareness of the disorder and related care, increasing investment in research, and rapidly